3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
37
Head & Neck
4
Thoracic
2
Dermatologic
2
Breast
2
Sarcoma
1
Other solid neoplasm
1
NET
1
Gynecologic
1
Genitourinary
1
Endocrine
1
CNS
1
Conditions
Sarcoma
111
Osteosarcoma
41
Sarcoma, Ewing
30
Rhabdomyosarcoma
28
Melanoma
28
Neuroblastoma
21
Glioblastoma
18
Bone Neoplasms
18
Rhabdoid Tumor
17
Lymphoma, Non-Hodgkin
17
Gliosarcoma
16
Neoplasms
15
Neoplasm Metastasis
15
Liposarcoma
15
Breast Neoplasms
15
Wilms Tumor
14
Ovarian Neoplasms
14
Glioma
14
Medulloblastoma
13
Leiomyosarcoma
13
Gastrointestinal Stromal Tumors
13
Carcinoma, Non-Small-Cell Lung
13
Stomach Neoplasms
12
Hepatoblastoma
12
Colorectal Neoplasms
12
Sarcoma, Synovial
11
Ependymoma
11
Chordoma
11
Carcinoma, Renal Cell
11
Neurofibrosarcoma
10
Interventions
Poly(ADP-ribose) Polymerase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Esophageal Squamous Cell Carcinoma
×
Sarcoma
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled